The RETECTANE brand, founded in 2008 (Germany), from 13 sister brands and 2214 competing brands. The RETECTANE brand is owned by Wilex, a company listed in Francfort. Its International Securities Identification Number (ISIN) is DE000A11QVV0. RETECTANE belongs to the Biotechnology business sector.

RETECTANE is a brand of Wilex (HPHA) Share price

International deposit : 2008 Business sector Biotechnology

Share price and profitability of the share Wilex (RETECTANE)

Buy Wilex share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 2.95

Portfolio valuation
Wilex (RETECTANE) over 5 years* EUR 2.70

Stock market history Wilex (RETECTANE)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Wilex

See more brands of Wilex

Rival brands
RETECTANE

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS